Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome

dc.contributor.author	Marrone, Luiz Carlos Porcello	pt_BR
dc.contributor.author	Marrone, Bianca Fontana	pt_BR
dc.contributor.author	Raya, Julia de La Puerta	pt_BR
dc.contributor.author	Gadonski, Giovani	pt_BR
dc.contributor.author	Costa, Jaderson Costa da	pt_BR
dc.date.accessioned	2019-05-11T02:38:15Z	pt_BR
dc.date.issued	2011	pt_BR
dc.identifier.issn	1662-6575	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/194183	pt_BR
dc.description.abstract	Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome.	en
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	Case Reports in Oncology. Philadelphia, USA. Vol. 4, n.1 (2011), p. 82-87	pt_BR
dc.rights	Open Access	en
dc.subject	Posterior reversible encephalopathy syndrome	en
dc.subject	Encefalopatias	pt_BR
dc.subject	Chemotherapy	en
dc.subject	Tratamento farmacológico	pt_BR
dc.subject	Farmacologia	pt_BR
dc.subject	Gemcitabine	en
dc.title	Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome	pt_BR
dc.type	Artigo de periódico	pt_BR
dc.identifier.nrb	000977618	pt_BR
dc.type.origin	Estrangeiro	pt_BR

Este item está licenciado na Creative Commons License